Obstructive Sleep Apnoea is Associated with Alterations in Markers of Fetoplacental Wellbeing.

  • Posted in Sleep Apnoea
  •  By Loran Simon

Obstructive sleep apnoea (OSA) has been associated with adverse foetal outcomes in some studies. Second trimester Down's syndrome screening markers reflect foetal and fetoplacental wellbeing. A new study aimed to compare markers of foetal and feto-placental wellbeing in women with OSA and low risk controls. A retrospective case-control study of pregnant women with OSA and available second trimester markers was performed. The researchers found out that OSA is associated with reduced serum uE3 levels, independently of BMI, possibly indicating foetal distress.

Read more here:
http://www.ncbi.nlm.nih.gov/pubmed/24712853

Somnowell Inventor - Visiting Professor Simon Ash FDS MSc MOrth BDS

Prof. Ash is the inventor of the highly successful SOMNOWELL Chrome device for snoring and sleep apnoea.

The Somnowell Chrome is made to exacting standards in the Somnowell laboratory under the supervision of Visiting Professor Simon Ash. Prof. Ash and his master technicians create each Somnowell Chrome device using their wealth of experience and expertise.

Prof. Ash works at the forefront of his profession. He is a Consultant and Specialist Orthodontist with over 30 years clinical experience, with a special interest in sleep related breathing disorders, TMJD, and bruxism. He currently works in Harley Street London and two private hospitals in London as part of a multi-disciplinary team managing snoring and sleep apnoea, and is Visiting Professor of Orthodontics at the BPP University.

The Somnowell mandibular advancement appliance is also recommended by:

  • Sleep Centres
  • ENT Surgeons, Sleep Physicians, Respiratory, Physicians
  • Orthodontists, Dentists
  • General Medical Practitioners
Recommended By:
Recommended By